Shionogi Buys Sciele: U.S. Sales Platform For Crestor Innovator
Executive Summary
Japanese drug maker Shionogi is paying $1.42 billion for a U.S. marketing platform
You may also be interested in...
Credit Woes Hitting Even Pharma
The pharmaceutical industry may take risks with R&D, but its disciplined approach to the balance sheet has helped insulate it from the rapidly spreading global credit mess. But even pharma will not be completely shielded
Credit Woes Hitting Even Pharma
The pharmaceutical industry may take risks with R&D, but its disciplined approach to the balance sheet has helped insulate it from the rapidly spreading global credit mess. But even pharma will not be completely shielded
Sciele, Addrenex Partner On Novel Hypertension Drug
Alpha adrenergic receptor agonist will enter Phase II clinical studies in the second half of the year.